Cargando…
Risk of transient vision loss after intravitreal aflibercept using vial-prepared vs. the novel prefilled syringe formulation
PURPOSE: To compare the risk of transient vision loss (TVL) probably attributable to a severe intraocular pressure spike after intravitreal aflibercept application using the novel prefilled syringe (PFS) vs. the established vial system (VS). METHODS: Datasets of the intravitreal injection service of...
Autores principales: | Klaas, Julian E., Bui, Vinh, Maierhofer, Niklas, Schworm, Benedikt, Maier, Mathias, Priglinger, Siegfried G., Siedlecki, Jakob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634539/ https://www.ncbi.nlm.nih.gov/pubmed/37954554 http://dx.doi.org/10.3389/fmed.2023.1295633 |
Ejemplares similares
-
Transient Vision Loss Associated with Prefilled Aflibercept Syringes: A Case Series and Analysis of Injection Force
por: Lee, Daniel J., et al.
Publicado: (2022) -
Incidence of severe rise in intraocular pressure after intravitreous injection of aflibercept with prefilled syringes
por: Dingerkus, Vita Louisa Sophie, et al.
Publicado: (2022) -
Prefilled syringes for intravitreal drug delivery
por: Sassalos, Thérèse M, et al.
Publicado: (2019) -
Re: Lee et al.: Transient vision loss associated with prefilled aflibercept syringes (Ophthalmol Sci. 2022;2:100115)
por: Raevis, Joseph
Publicado: (2022) -
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
por: Schworm, Benedikt, et al.
Publicado: (2020)